• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo

tetano

Editor, Senior Moderator
J Virol. 2016 Oct 19. pii: JVI.01813-16. [Epub ahead of print]
[h=1]CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo.[/h] Teng O[SUP]1,[/SUP][SUP]2[/SUP], Chen ST[SUP]3[/SUP], Hsu TL[SUP]4[/SUP], Sia SF[SUP]2[/SUP], Cole S[SUP]2[/SUP], Valkenburg SA[SUP]1,[/SUP][SUP]2[/SUP], Hsu TY[SUP]3[/SUP], Zheng JT[SUP]5[/SUP], Tu W[SUP]5[/SUP], Bruzzone R[SUP]1,[/SUP][SUP]2[/SUP], Peiris JS[SUP]1,[/SUP][SUP]2[/SUP], Hsieh SL[SUP]6,[/SUP][SUP]4,[/SUP][SUP]7[/SUP], Yen HL[SUP]8,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Human infections with influenza viruses exhibit mild to severe clinical outcome as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin member 5A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of pro-inflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced TNF-α and IP-10 but elevated IFN-α compared to wild-type mice. The heightened type-I IFN response in the macrophages of CLEC5A-deficient mice was associated with up-regulated TLR3 mRNA after treatment with double stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of pro-inflammatory cytokines, decreased immune cell infiltration in the lungs and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered as a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections.
[h=4]IMPORTANCE:[/h] Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response at gate to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of pro-inflammatory cytokines and chemokines in myeloid cells after influenza infections. CLEC5A-deficient mice infected with influenza virus showed reduced inflammation in the lungs and improved survival than the wild-type mice, despite comparable viral loads. The survival difference was more prominent at a lower dose of inoculum. Collectively, our results suggest that dampening CLEC5A-mediated inflammatory responses in myeloid cells may reduce immunopathogenesis after influenza infections.
Copyright ? 2016 Teng et al.


PMID: 27795434 DOI: 10.1128/JVI.01813-16
[PubMed - as supplied by publisher] Free full text
 
Back
Top